[ Price : $8.95]
PhRMA suggests that FDA revise a draft guidance on QTc labeling to incorporate an International Council on Harmonization guideline...[ Price : $8.95]
Reporting positive data from a Phase 3 study on mirikizumab in Crohns disease, Eli Lilly says it will seek FDA approval for the dr...[ Price : $8.95]
Rep. Abigail Spanberger and 14 Democratic colleagues ask FDA and DEA for more information on their work to resolve shortages of AD...[ Price : $8.95]
FDA lifts a clinical hold against PepGen that will allow the company to begin the Phase 1 FREEDOM-DM1 study of PGN-EDODM1 in patie...[ Price : $8.95]
FDA grants MimiVax a fast track designation for its SurVaxM vaccine that is being studied for treating newly diagnosed glioblastom...[ Price : $8.95]
FDA says it will accept until 12/11 applications for its new Digital Health Technologies Advisory Committee.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection entitled Regulations for In Vivo Radiopharmaceuticals Use...[ Price : $8.95]
A Tufts Center for Biomedical System Design analysis says cell and gene therapies are more likely to be successful than other ther...